检索结果 - Hiroki Oe
- Showing 1 - 6 results of 6
-
1
Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial 由 Hiroki Oe, Kazufumi Nakamura, Hajime Kihara, Kenei Shimada, Shota Fukuda, Tsutomu Takagi, Toru Miyoshi, Kumiko Hirata, Junichi Yoshikawa, Hiroshi Ito
出版 2015Artigo -
2
-
3
Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats 由 Toru Miyoshi, Kazufumi Nakamura, Masashi Yoshida, Daiji Miura, Hiroki Oe, Satoshi Akagi, Hiroki Sugiyama, Kaoru Akazawa, Tomoko Yonezawa, Jun Wada, Hiroshi Ito
出版 2014Artigo -
4
-
5
DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study 由 Kazufumi Nakamura, Hiroki Oe, Hajime Kihara, Kenei Shimada, Shota Fukuda, Kyoko Watanabe, Tsutomu Takagi, Kei Yunoki, Toru Miyoshi, Kumiko Hirata, Jun–ichi Yoshikawa, Hiroshi Ito
出版 2014Artigo -
6
Beta-Blockers and Oxidative Stress in Patients with Heart Failure 由 Kazufumi Nakamura, Masato Murakami, Daiji Miura, Kei Yunoki, Kenki Enko, Masamichi Tanaka, Yukihiro Saito, Nobuhiro Nishii, Toru Miyoshi, Masashi Yoshida, Hiroki Oe, Norihisa Toh, Satoshi Nagase, Kunihisa Kohno, Hiroshi Morita, Hiromi Matsubara, Kengo Kusano, Tohru Ohe, Hiroshi Ito
出版 2011Revisão
相关主题
Internal medicine
Medicine
Diabetes mellitus
Dipeptidyl peptidase-4 inhibitor
Endocrinology
Type 2 diabetes
Cardiology
Dipeptidyl peptidase-4
Blood pressure
Clinical endpoint
Endothelial dysfunction
Pharmacology
Pioglitazone
Postprandial
Sitagliptin
Type 2 Diabetes Mellitus
Adrenergic
Alogliptin
Angiology
Area under the curve
BETA (programming language)
Biochemistry
Brachial artery
Cardiac hypertrophy
Chemistry
Clinical Practice
Clinical trial
Computer science
Cost effectiveness
Diagnostic accuracy